Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
15 Oct 2021
Historique:
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 14 10 2021
Statut: ppublish

Résumé

Single-cell epigenomic assays have tremendous potential to illuminate mechanisms of transcriptional control in functionally diverse cancer cell populations. However, application of these techniques to clinical tumor specimens has been hampered by the current inability to distinguish malignant from nonmalignant cells, which potently confounds data analysis and interpretation. Here, we describe Copy-scAT, an R package that uses single-cell epigenomic data to infer copy number variants (CNVs) that define cancer cells. Copy-scAT enables studies of subclonal chromatin dynamics in complex tumors like glioblastoma. By deploying Copy-scAT, we uncovered potent influences of genetics on chromatin accessibility profiles in individual subclones. Consequently, some genetic subclones were predisposed to acquire stem-like or more differentiated molecular phenotypes, reminiscent of developmental paradigms. Copy-scAT is ideal for studies of the relationships between genetics and epigenetics in malignancies with high levels of intratumoral heterogeneity and to investigate how cancer cells interface with their microenvironment.

Identifiants

pubmed: 34644115
doi: 10.1126/sciadv.abg6045
pmc: PMC8514091
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabg6045

Références

Nature. 2019 Aug;572(7767):67-73
pubmed: 31043743
Nat Commun. 2019 Apr 23;10(1):1903
pubmed: 31015418
Science. 2017 Mar 31;355(6332):
pubmed: 28360267
Nature. 2015 Jul 23;523(7561):486-90
pubmed: 26083756
Cell Rep. 2017 Oct 31;21(5):1399-1410
pubmed: 29091775
Nature. 2016 Nov 10;539(7628):309-313
pubmed: 27806376
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Cancer Res. 2019 May 1;79(9):2111-2123
pubmed: 30877103
Nat Methods. 2017 Oct;14(10):975-978
pubmed: 28825706
Cell. 2019 Aug 8;178(4):835-849.e21
pubmed: 31327527
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Bioinformatics. 2018 Sep 15;34(18):3217-3219
pubmed: 29897414
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cancer Cell. 2011 Dec 13;20(6):810-7
pubmed: 22137795
R J. 2016 Aug;8(1):289-317
pubmed: 27818791
Nucleic Acids Res. 2018 Jan 4;46(D1):D1284
pubmed: 29161433
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Cancer Cell. 2015 Sep 14;28(3):307-317
pubmed: 26373278
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Cancer Cell. 2020 Apr 13;37(4):456-470
pubmed: 32289270
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Cancer Cell. 2020 Jul 13;38(1):44-59.e9
pubmed: 32663469

Auteurs

Ana Nikolic (A)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Divya Singhal (D)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Katrina Ellestad (K)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Michael Johnston (M)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Yaoqing Shen (Y)

Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Aaron Gillmor (A)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Sorana Morrissy (S)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

J Gregory Cairncross (JG)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Steven Jones (S)

Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Mathieu Lupien (M)

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Ontario Institute for Cancer Research, Toronto, ON, Canada.

Jennifer A Chan (JA)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Paola Neri (P)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Nizar Bahlis (N)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Marco Gallo (M)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Classifications MeSH